DGTL Holdings Inc. Secures Annual PaaS Subscription Contract Renewal with National U.S. Sports League
Major National League Signs Its Fifth Year Subscription to TotalSocial Data and Analytics PaaS New…
Month: October 2022
Aquarius AI Inc. Announces Agreement to Acquire Jellyworks Inc.
Vancouver, British Columbia–(Newsfile Corp. – October 5, 2022) – Aquarius AI Inc. (CSE: AQUA) (the “Company”…
Lobe Sciences Announces the Appointment of Baxter F. Phillips III to Its Board of Directors
Vancouver, British Columbia–(Newsfile Corp. – October 5, 2022) – Lobe Sciences Ltd. (CSE: LOBE) (OTCQB:…
KBRA Releases Research – Potential ABS Exposure to Hurricane Ian
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research on potential ABS exposure in our rated universe of consumer…
New Jersey Transit Innovation Team Named Winner in Second Annual IDC Best in Future of Digital Innovation Awards
NEEDHAM, Mass.–(BUSINESS WIRE)–#DigitalInnovation–International Data Corporation (IDC) today announced winners of the second annual IDC Future…
Enreach further strengthens European footprint with acquisitions in the Netherlands and Denmark
Almere 5 October 2022 – Enreach, one of Europe’s fastest growing providers of converged contact…
Continued Rise In Ransomware Drives Growth For ProLion
Ransomware and insider threat protection solutions provider achieves continued global growth for FY2022, including 80…
MBX Biosciences Advances Phase 1 Clinical Trial of Long-Acting Parathyroid Hormone Peptide Prodrug, MBX 2109
MBX 2109 is in clinical development for treatment of hypoparathyroidism CARMEL, Ind., Oct. 05, 2022…
AnaptysBio and GSK-partnered immuno-oncology agents JEMPERLI (dostarlimab-gxly) and cobolimab show positive progress in two separate non-small cell lung cancer trials
Positive headline results from PERLA, a head-to head Phase 2 trial of JEMPERLI vs. Keytruda…
Oxford Biomedica Solutions to Present Company Capabilities & Its Platform at Cell & Gene Meeting on the Mesa and European Society of Gene & Cell Therapy
BEDFORD, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — Oxford Biomedica Solutions LLC, an Oxford Biomedica…
TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
WALTHAM, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
Evaxion welcomes Per Norlén as new CEO.
COPENHAGEN, Denmark, Oct. 05, 2022 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
Yield10 Bioscience Appoints Willie Loh, Ph.D., Former Cargill Executive, to the Board of Directors
WOBURN, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the…
Longeveron to Present at the Annual Dawson James Small Cap Growth Conference
MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Agenus to Host “The Road Taken” R&D Event on November 12, 2022
LEXINGTON, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with…
Acer Therapeutics Announces Expansion of ACER-801 (osanetant) Development Indications to Include Post-Traumatic Stress Disorder
Licensed exclusive worldwide rights from Emory University to patents and patent applications for certain methods…
ABVC BioPharma Announces Vitargus® Phase II Study Plan Approved by HREC in Australia
FREMONT, CA, Oct. 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
Fortress Biotech Announces Timing of Regular Monthly Dividend for October, November and December 2022 for its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Common Stock: Nasdaq: FBIO) (Preferred…
Albireo to Showcase New Data at AASLD The Liver Meeting® 2022
– Seven abstracts accepted, including one oral presentation highlighting long-term data demonstrating Bylvay® (odevixibat) durable…
23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
Poster to provide details on study design and expansion phase for ongoing Phase 1 study…